Elsevier regrets faux journals

Share this article:
Elsevier came under fire for a series of deceptive publications published in Australia between 2000 and 2005. The six journals in question, published by Elsevier's Excerpta Medica, resembled legitimate journals, but were in fact sponsored compilations created “on behalf of pharmaceutical clients…and lack[ing] the proper disclosures,” said Michael Hanson, CEO of Elsevier's health sciences division, in a statement. “This was an unacceptable practice, and we regret that it took place.”

One of the journals, Australasian Journal of Bone and Joint Medicine, was allegedly produced entirely by Merck to promote Vioxx, according to a report in The Australian.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.